Drug Type Small molecule drug |
Synonyms 2-(Methoxycarbonyl)phenol, 2-Carbomethoxyphenol, 2-Hydroxybenzoic acid methyl ester + [15] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Jan 1974) |
Regulation- |
Molecular FormulaC8H8O3 |
InChIKeyOSWPMRLSEDHDFF-UHFFFAOYSA-N |
CAS Registry119-36-8 |
Start Date11 Jan 2024 |
Sponsor / Collaborator |
Start Date25 Nov 2022 |
Sponsor / Collaborator |
Start Date25 May 2022 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01087 | Methyl Salicylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | China | 01 Jan 1992 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | - | (Peppermint essential oil) | zfzipaclwb(lrmpokrsqw) = oitxkhcfdl dnedpblhor (cehmascdob ) View more | - | 01 Feb 2023 | ||
(Ginger essential oil) | zfzipaclwb(lrmpokrsqw) = ytuinhvfme dnedpblhor (cehmascdob ) View more |